@phdthesis{Haug2014,
  author    = {Haug, Daniela},
  title     = {Untersuchung von FOSL1 im humanen Melanom},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-91064},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2014},
  abstract  = {Bei Melanomen handelt es sich um die gef{\"a}hrlichste Form von Hautkrebs mit der h{\"o}chsten Mortalit{\"a}tsrate. Deshalb sind Untersuchungen dieser Hautkrebsart von immenser Bedeutung. Es ist bekannt, dass der AP-1-Transkriptionsfaktorkomplex eine große Rolle f{\"u}r Melanomentstehung und -progression spielt. In der vorliegenden Arbeit wurde die Funktion der AP-1 Komponente FOSL1 in Melanomen untersucht. Hierbei konnte zun{\"a}chst ermittelt werden, dass die FOSL1 Expression im humanen Melanom durch den MAPK-Signalweg vermittelt wird und von den Onkogenen BRAF und NRAS abh{\"a}ngig ist. Dies wird auch durch die Tatsache unterst{\"u}tzt, dass die Stabilit{\"a}t von FOSL1 durch MAPK reguliert wird. Des Weiteren konnte gezeigt werden, dass FOSL1 in vielen Melanomzellen die Proliferation verst{\"a}rkt und auch an Migration beteiligt ist. Da diese Prozesse zur Krebsprogression beitragen, deutet dies darauf hin, dass FOSL1 bei der Melanomentwicklung eine wichtige Funktion besitzt. Weiterhin konnten SLUG, SNAI3, IL6 und MMP14 als FOSL1-Zielgene identifiziert werden, deren Regulierbarkeit durch FOSL1, jedoch abh{\"a}ngig von der jeweiligen Zelllinie war. Somit konnte mit dieser Arbeit gezeigt werden, dass FOSL1 nicht nur, wie zuvor f{\"u}r Brustkrebszellen beschrieben, an Migration beteiligt ist, sondern auch zur Proliferation humaner Melanome beitr{\"a}gt. Zuk{\"u}nftige Arbeiten werden zeigen, ob die identifizierten Gene f{\"u}r die FOSL1-vermittelte Migration und Proliferation verantwortlich sind.},
  subject      = {Proliferation},
  language  = {de}
}
@phdthesis{Schaafhausen2014,
  author    = {Schaafhausen, Maximilian},
  title     = {Development of a fish melanoma angiogenesis model},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-101043},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2014},
  abstract  = {Malignant melanoma is the most severe form of all skin cancers with a particular poor prognosis once metastases have developed. Angiogenesis, the formation of new blood vessels, is a prominent feature of human melanoma, which have angiogenic activity already early in development. This is at least partly ascribed to the action of MAPK- and PI3K pathways which are hyperactivated in most melanoma. Animal models which combine in depth in vivo examinations with the opportunity to perform small molecular screens are well suited to gain a more detailed insight into how this type of cancer modulates its angiogenic program. Here, a first transgenic melanoma angiogenesis model was established in the fish species Oryzias latipes (Japanese medaka). In this model, tumors are generated by the pigment cell-specific expression of the oncogenic receptor tyrosine kinase Xmrk. Xmrk is a mutated version of the fish Egfp. Furthermore, to get an angiogenesis model, a medaka line with endothelial cell specific GFP expression was used. By using crosses between these Xmrk- and GFP transgenic fishes, it was shown that angiogenesis occurs in a reactive oxygen species- and NF-κB-dependent manner, but was hypoxia-independent. It was observed that blood vessel sprouting and branch point formation was elevated in this model and furthermore that sprouting could even be induced by single transformed cells. The mouse melanocytes expressing the oncogenic receptor tyrosine kinase Xmrk as well human melanoma cells, which display various oncogenic alterations, produced pro-angiogenic factors, most prominently angiogenin, via NF-κB signaling. Furthermore, inhibiting NF-κB action prevented tumor angiogenesis and even led to the regression of existing tumor blood vessels. In summary, the present medaka melanoma angiogenesis model displays a high sensitivity for angiogenesis detection and is perfectly suited as in vivo model for the testing of anti-angiogenesis inhibitors, as exemplified by the NF-kappaB inhibitor. Furthermore, results indicate that it might be a promising anti-tumor strategy to target signaling pathways such as the NF-κB pathway which are able to induce angiogenesis-dependent as well as -independent pro-tumorigenic effects.},
  subject      = {Melanom},
  language  = {en}
}